Cholera Vaccine
- TRADE NAME: Vaxchora (PaxVax)
- INDICATIONS: Immunization against cholera for adults traveling to cholera-affected areas
- CLASS: Vaccine
- HALF-LIFE: N/A
FDA APPROVAL DATE: 06/10/2016
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:Antibiotics, Chloroquine
PREGNANCY CATEGORY: N/A
Not expected to cause fetal risk
Please login to see the rest of this drug profile
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric